Skip to main content
Erschienen in: Obesity Surgery 4/2008

01.04.2008 | Research Article

Non-alcoholic Fatty Liver Disease and Its Relationship with the Nutritional Status of Vitamin A in Individuals with Class III Obesity

verfasst von: Gabriela Villaça Chaves, Silvia Elaine Pereira, Carlos José Saboya, Andréa Ramalho

Erschienen in: Obesity Surgery | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of the present study was to investigate vitamin A nutritional status in individuals with class III obesity through a biochemical indicator (retinol and β-carotene serum levels), correlating these findings with non-alcoholic fatty liver disease (NAFLD) presence and its risk factors.

Methods

The studied population was composed of 145 patients with morbid obesity [body mass index, BMI ≥ 40 kg/m2) of both sexes. Retinol and β-carotene serum levels were assessed by high performance liquid chromatography. The cutoff values used for serum retinol and β-carotene inadequacy were <1.05 μmol/l and ≤40 μg/dl, respectively. Insulin resistance (IR) was assessed through homeostasis model assessment index (HOMA) method. Biochemical parameters of liver enzymes, lipid profile, and glycemia were analyzed. Anthropometric measurements were conducted. NAFLD diagnosis was performed through magnetic resonance.

Results

NAFLD prevalence in the group was 71%. An inadequacy of 11.3 and 41.7% of retinol and β-carotene serum levels, respectively, was found when NAFLD was present. A significant correlation of serum retinol with albumin liver and total bilirubin was found. As regards β-carotene, a positive correlation for HDL-c variable and a negative correlation for the HOMA-IR, weight, and BMI variables were observed. There was a significant association between IR presence and retinol and β-carotene inadequacy.

Conclusion

The high inadequacy of retinol and β-carotene nutritional status in the sample, with a higher inadequacy in those with NAFLD, suggests an increase in the utilization of vitamin A in this group related to the fight against the oxidative stress to what they are exposed to. The significant association between retinol and β-carotene with IR supports the hypothesis that vitamin A may have a protector effect on IR pathogenesis.
Literatur
1.
Zurück zum Zitat Harrison AS, Bisceglie AM. Advances in the understanding and treatment on nonalcoholic fatty liver disease. Drugs 2003;63:2379–94.PubMedCrossRef Harrison AS, Bisceglie AM. Advances in the understanding and treatment on nonalcoholic fatty liver disease. Drugs 2003;63:2379–94.PubMedCrossRef
2.
Zurück zum Zitat Ruhl CE, Everhart JE. Epidemiology of non-alcoholic fatty liver. Clin Liver Dis. 2004;8:501–19.PubMedCrossRef Ruhl CE, Everhart JE. Epidemiology of non-alcoholic fatty liver. Clin Liver Dis. 2004;8:501–19.PubMedCrossRef
3.
Zurück zum Zitat Ludwig J, Vigginao TR, Mc Gill DB. Nonalcoholic steatohepatitis. Mayo Clin Proc. 1980;55:434–8.PubMed Ludwig J, Vigginao TR, Mc Gill DB. Nonalcoholic steatohepatitis. Mayo Clin Proc. 1980;55:434–8.PubMed
4.
Zurück zum Zitat Matteoni CA, Younossi AM, Gramlich, T. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–9.PubMedCrossRef Matteoni CA, Younossi AM, Gramlich, T. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–9.PubMedCrossRef
6.
Zurück zum Zitat WHO (World Health Organization). Global prevalence of vitamin A deficiency. WHO/NUT/95.3. Geneva: WHO; 1995 WHO (World Health Organization). Global prevalence of vitamin A deficiency. WHO/NUT/95.3. Geneva: WHO; 1995
7.
Zurück zum Zitat Institute of Medicine (IOM). Vitamin A. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington: National Academy Press; 2001. p. 82–161. Institute of Medicine (IOM). Vitamin A. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington: National Academy Press; 2001. p. 82–161.
8.
Zurück zum Zitat Delport R, Ubbink JB, Human JA, et al. Antioxidant vitamins and coronary artery disease risk in South African males. Clin Chim Acta. 1998;278:55–60.PubMedCrossRef Delport R, Ubbink JB, Human JA, et al. Antioxidant vitamins and coronary artery disease risk in South African males. Clin Chim Acta. 1998;278:55–60.PubMedCrossRef
9.
Zurück zum Zitat Sarni RO, Ramalho RA. Serum retinol and total carotene concentrations in obese children. Med Sci Monit. 2005;11:510–4. Sarni RO, Ramalho RA. Serum retinol and total carotene concentrations in obese children. Med Sci Monit. 2005;11:510–4.
10.
Zurück zum Zitat Souza LB, Veiga GV, Ramalho RA. Níveis séricos de retinol e carotenóides e sua associação com o estado nutricional antropométrico em escolares e adolescentes. Rev SOCERJ 2004;17:147. Souza LB, Veiga GV, Ramalho RA. Níveis séricos de retinol e carotenóides e sua associação com o estado nutricional antropométrico em escolares e adolescentes. Rev SOCERJ 2004;17:147.
11.
Zurück zum Zitat Cuppari L. Guias de Medicina Ambulatorial e Hospitalar. Nutrição Clínica no Adulto. UNIFESP. São Paulo: Manole; 2002. Cuppari L. Guias de Medicina Ambulatorial e Hospitalar. Nutrição Clínica no Adulto. UNIFESP. São Paulo: Manole; 2002.
12.
Zurück zum Zitat World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. WHO: Geneva; 1998. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. WHO: Geneva; 1998.
13.
Zurück zum Zitat World Health Organization. Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. Micronutrient Series, WHO/NUT. 10. Geneva, Switzerland: World Health Organization; 1996. World Health Organization. Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. Micronutrient Series, WHO/NUT. 10. Geneva, Switzerland: World Health Organization; 1996.
14.
Zurück zum Zitat IVACG (International Vitamin A Consultative Group). Improving the vitamin A status of populations. USAID-ILSI; 2003. IVACG (International Vitamin A Consultative Group). Improving the vitamin A status of populations. USAID-ILSI; 2003.
15.
Zurück zum Zitat Sauberlich HE, Hodges RE, Wallace DL. Vitamin A metabolism and requirements in the human studied with the use of labeled retinol. Vitam Horm. 1974;32:251–75.PubMedCrossRef Sauberlich HE, Hodges RE, Wallace DL. Vitamin A metabolism and requirements in the human studied with the use of labeled retinol. Vitam Horm. 1974;32:251–75.PubMedCrossRef
16.
Zurück zum Zitat Matthews D, Hosker J, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.PubMedCrossRef Matthews D, Hosker J, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.PubMedCrossRef
17.
Zurück zum Zitat V Diretrizes Brasileiras de Hipertensão Arterial 2006; Sociedade Brasileira de Cardiologia (SBC); Sociedade Brasileira de Hipertensão (SBH); Sociedade Brasileira de Nefrologia. São Paulo; 2006. V Diretrizes Brasileiras de Hipertensão Arterial 2006; Sociedade Brasileira de Cardiologia (SBC); Sociedade Brasileira de Hipertensão (SBH); Sociedade Brasileira de Nefrologia. São Paulo; 2006.
18.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28:S4–36.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28:S4–36.CrossRef
19.
Zurück zum Zitat Crespo J, Fernández-Gil P, Hernández-Guerra M, et al. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? Obes Surg. 2001;11:254–7.PubMedCrossRef Crespo J, Fernández-Gil P, Hernández-Guerra M, et al. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? Obes Surg. 2001;11:254–7.PubMedCrossRef
20.
Zurück zum Zitat Papadia FS, Marinari GM, Camerini G, et al. Liver damage in severely obese patients: a clinical–biochemical–morphologic study on 1,000 liver biopsies. Obes Surg. 2004;14:952–8.PubMedCrossRef Papadia FS, Marinari GM, Camerini G, et al. Liver damage in severely obese patients: a clinical–biochemical–morphologic study on 1,000 liver biopsies. Obes Surg. 2004;14:952–8.PubMedCrossRef
21.
Zurück zum Zitat Garcia-Monzon C, Martin-Perez E, Lacono OL, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33:716–24.PubMedCrossRef Garcia-Monzon C, Martin-Perez E, Lacono OL, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33:716–24.PubMedCrossRef
22.
Zurück zum Zitat Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14:635–7.PubMedCrossRef Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14:635–7.PubMedCrossRef
23.
Zurück zum Zitat Wolf AM, Busch B, Kuhlmann HW, et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg. 2005;15:228–37.PubMedCrossRef Wolf AM, Busch B, Kuhlmann HW, et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg. 2005;15:228–37.PubMedCrossRef
24.
Zurück zum Zitat Arun J, Clements RH, Lazenby AJ, et al. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg. 2006;16:1351–8.PubMedCrossRef Arun J, Clements RH, Lazenby AJ, et al. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg. 2006;16:1351–8.PubMedCrossRef
25.
Zurück zum Zitat Sarni RS, Pitta TS, Fernández AP, et al. Avaliação da peroxidação lipídica e nível sérico de retinol e carotenóides em crianças e adolescentes matriculados em escola pública do município de Santo André, São Paulo. RAMB 2002;48:48–53. Sarni RS, Pitta TS, Fernández AP, et al. Avaliação da peroxidação lipídica e nível sérico de retinol e carotenóides em crianças e adolescentes matriculados em escola pública do município de Santo André, São Paulo. RAMB 2002;48:48–53.
26.
Zurück zum Zitat Mecocci P, Polidori MC, Troiano L, et al. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med. 2000;28:1243–8.PubMedCrossRef Mecocci P, Polidori MC, Troiano L, et al. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med. 2000;28:1243–8.PubMedCrossRef
27.
Zurück zum Zitat Gopal DV, Rosen HR. Abnormal findings on liver function tests. Postgrad Med. 2000;107:100–14.PubMed Gopal DV, Rosen HR. Abnormal findings on liver function tests. Postgrad Med. 2000;107:100–14.PubMed
28.
Zurück zum Zitat Rocchi E, Borghi A, Paolillo F, et al. Carotenoids and liposoluble vitamins in liver cirrhosis. J Lab Clin Med. 1991;118:176–85.PubMed Rocchi E, Borghi A, Paolillo F, et al. Carotenoids and liposoluble vitamins in liver cirrhosis. J Lab Clin Med. 1991;118:176–85.PubMed
29.
Zurück zum Zitat Newsome PN, Beldon I, Moussa Y, et al. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther. 2000;14:1295–301.PubMedCrossRef Newsome PN, Beldon I, Moussa Y, et al. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther. 2000;14:1295–301.PubMedCrossRef
30.
Zurück zum Zitat Romagnuolo J, Andrews C, Bain VG, et al. Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model. Scand J Gastroenterol. 2005;40:1365–71.PubMedCrossRef Romagnuolo J, Andrews C, Bain VG, et al. Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model. Scand J Gastroenterol. 2005;40:1365–71.PubMedCrossRef
31.
Zurück zum Zitat Peres, WA. Relação entre o estado nutricional de vitamina a, estágios da doença e parâmetros bioquímicos de função e lesão hepática em pacientes com hepatite crônica, cirrose hepática e carcinoma hepatocelular pelo virus c. Rio de Janeiro, 2006. Dissertação (Doutorado). Universidade Federal do Rio de Janeiro. Peres, WA. Relação entre o estado nutricional de vitamina a, estágios da doença e parâmetros bioquímicos de função e lesão hepática em pacientes com hepatite crônica, cirrose hepática e carcinoma hepatocelular pelo virus c. Rio de Janeiro, 2006. Dissertação (Doutorado). Universidade Federal do Rio de Janeiro.
32.
Zurück zum Zitat Santos HS, Cruz WM. A terapia nutricional com vitaminas oxidantes e o tratamento quimioterápico oncológico. Rev Bras Cancerol. 2001;47:303–8. Santos HS, Cruz WM. A terapia nutricional com vitaminas oxidantes e o tratamento quimioterápico oncológico. Rev Bras Cancerol. 2001;47:303–8.
33.
Zurück zum Zitat Sigiura M, Nakamura M, Ikoma Y, et al. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol. 2006;16:71–8. Sigiura M, Nakamura M, Ikoma Y, et al. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol. 2006;16:71–8.
34.
Zurück zum Zitat Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia 1996;39:357–63.PubMedCrossRef Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia 1996;39:357–63.PubMedCrossRef
35.
Zurück zum Zitat Facchini FS, Humphreys MH, DoNascimento CA, et al. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr. 2000;72:776–9.PubMed Facchini FS, Humphreys MH, DoNascimento CA, et al. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr. 2000;72:776–9.PubMed
36.
Zurück zum Zitat Ford ES, Will JC, Bowman BA, et al. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999;149:168–76.PubMed Ford ES, Will JC, Bowman BA, et al. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999;149:168–76.PubMed
37.
Zurück zum Zitat Viroonudomphol D, Pongpaew P, Tungtrongchitr R, et al. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr. 2003;12:73–9.PubMed Viroonudomphol D, Pongpaew P, Tungtrongchitr R, et al. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr. 2003;12:73–9.PubMed
Metadaten
Titel
Non-alcoholic Fatty Liver Disease and Its Relationship with the Nutritional Status of Vitamin A in Individuals with Class III Obesity
verfasst von
Gabriela Villaça Chaves
Silvia Elaine Pereira
Carlos José Saboya
Andréa Ramalho
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 4/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9361-2

Weitere Artikel der Ausgabe 4/2008

Obesity Surgery 4/2008 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.